Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kalinox versus oxygen for analgesia during intradetrusor botulinum toxin A injections
2006-005352-32Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2007
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitrous oxide + oxygen in neurogenic bladder (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Primary efficacy endpoint. Started Nov 2007; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on 2006-005352-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005352-32.